Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy

समान संसाधन

• Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases
  द्वारा: Zhang, Guowei, और अन्य
  प्रकाशित: (2017)
• Efficacy of crizotinib and pemetrexed-based chemotherapy in Chinese NSCLC patients with ROS1 rearrangement
  द्वारा: Zhang, Limin, और अन्य
  प्रकाशित: (2016)
• Characterization of distinct types of KRAS mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancer
  द्वारा: Jia, Yijun, और अन्य
  प्रकाशित: (2017)
• Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
  द्वारा: Wen, Miaomiao, और अन्य
  प्रकाशित: (2018)
• Exosomes transmit T790M mutation‐induced resistance in EGFR‐mutant NSCLC by activating PI3K/AKT signalling pathway
  द्वारा: Liu, Xiaozhen, और अन्य
  प्रकाशित: (2020)